When Is Genome Sequencing Advisable?
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Global Lab Network Expands Measles, Rubella Surveillance Capacity
From - Diagnostic Testing & Emerging Technologies
From 2010 to 2015 the Global Measles and Rubella Laboratory Network (GMRLN) substantially increased its capacity to provide real-time disease surveillance and…
Exome Sequencing May Enable Prenatal Diagnosis, Management
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Utility of Post Op Lab Testing Questioned for Some Gynecologic Patients
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Genetic Predisposition to Stress Fractures ID’d in Healthy Individuals
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
States Eye Expanding Roadside Drug Tests as Law Enforcement Implements Oral Fluid Testing Pilots
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Cotesting Best for Cervical Cancer Screening, But Cytology Doesn’t ID Other Gynecological Cancers
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Low Histopathologic Agreement for DCIS, Atypia Breast Cancer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
